BioMarin

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade BioMarin 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMRN

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. 

CEO
Alexander Hardy
CEOAlexander Hardy
Employees
3,040
Employees3,040
Headquarters
San Rafael, California
HeadquartersSan Rafael, California
Founded
1997
Founded1997
Employees
3,040
Employees3,040

BMRN Key Statistics

Market cap
11.02B
Market cap11.02B
Price-Earnings ratio
21.11
Price-Earnings ratio21.11
Dividend yield
Dividend yield
Average volume
2.45M
Average volume2.45M
High today
$58.17
High today$58.17
Low today
$56.53
Low today$56.53
Open price
$57.10
Open price$57.10
Volume
1.69M
Volume1.69M
52 Week high
$94.85
52 Week high$94.85
52 Week low
$52.93
52 Week low$52.93

Analyst ratings

81%

of 31 ratings
Buy
80.6%
Hold
19.4%
Sell
0%

People also own

Based on the portfolios of people who own BMRN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.